Caris Life Sciences, Inc. (CAI) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $577.31M | +123.1% |
| 2024 | -$2.50B | -16.5% |
| 2023 | -$2.14B | -26.0% |
| 2022 | -$1.70B | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $577.31M | +123.1% |
| 2024 | -$2.50B | -16.5% |
| 2023 | -$2.14B | -26.0% |
| 2022 | -$1.70B | — |